Thermo Fisher Scientific (TMO) Income towards Parent Company (2009 - 2026)

Thermo Fisher Scientific has disclosed Income towards Parent Company across 18 years of filings, most recently posting $1.7 billion for Q1 2026.

• Quarterly Income towards Parent Company rose 6.35% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 6.35% YoY) and the FY2025 annual result came in at $6.8 billion, up 5.32% from the prior year.
• Income towards Parent Company fell to $1.7 billion in Q1 2026, from $2.0 billion in the prior quarter.
• Over five years, Income towards Parent Company peaked at $2.2 billion in Q2 2022 and troughed at $1.3 billion in Q2 2023.
• A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 frame the typical range for Income towards Parent Company.
• Annual changes were most pronounced in 2023 — Income towards Parent Company slumped 41.94% — and 2024, when it climbed 24.17%.
• Tracing TMO's Income towards Parent Company over 5 years: stood at $1.6 billion in 2022, then rose by 4.39% to $1.6 billion in 2023, then advanced by 12.73% to $1.8 billion in 2024, then advanced by 9.27% to $2.0 billion in 2025, then retreated by 16.86% to $1.7 billion in 2026.
• Business Quant data shows TMO's Income towards Parent Company at $1.7 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.6 billion in Q3 2025.